Limited Value of Cystatin-C over Estimated Glomerular Filtration Rate for Heart Failure Risk Stratification

• Elisabet Zamora,

  Affiliations Heart Failure Unit, Hospital Universitari Germans Trias i Pujol, Badalona, Spain, Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain

  ⨯
• Josep Lupón,

  Affiliations Heart Failure Unit, Hospital Universitari Germans Trias i Pujol, Badalona, Spain, Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain

  ⨯
• Marta de Antonio,

  Affiliations Heart Failure Unit, Hospital Universitari Germans Trias i Pujol, Badalona, Spain, Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain

  ⨯
• Joan Vila,

  Affiliations Inflammatory and Cardiovascular Disease Programme, IMIM-Hospital del Mar Research Institute, Barcelona, Spain, CIBER Epidemiology and Public Health, Barcelona, Spain

  ⨯
• Amparo Galán,

  Affiliation Biochemistry Service, Hospital Universitari Germans Trias i Pujol, Badalona, Spain

  ⨯
• Paloma Gastelurrutia,

  Affiliation Heart Failure Unit, Hospital Universitari Germans Trias i Pujol, Badalona, Spain

  ⨯
• Agustín Urrutia,

  Affiliations Heart Failure Unit, Hospital Universitari Germans Trias i Pujol, Badalona, Spain, Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain

  ⨯
• Antoni Bayes-Genis

  * E-mail: abayesgenis@gmail.com

  Affiliations Heart Failure Unit, Hospital Universitari Germans Trias i Pujol, Badalona, Spain, Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain

  ⨯